Literature DB >> 27533635

Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer.

Allison Lipitz-Snyderman1, Camelia S Sima2, Coral L Atoria1, Elena B Elkin1, Christopher Anderson3, Victoria Blinder4, Chiaojung Jillian Tsai5, Katherine S Panageas6, Peter B Bach1.   

Abstract

IMPORTANCE: Interventions to address overuse of health care services may help reduce costs and improve care. Understanding physician-level variation and behavior patterns can inform such interventions.
OBJECTIVE: To assess patterns of physician ordering of services that tend to be overused in the treatment of patients with cancer. We hypothesized that physicians exhibit consistent behavior. DESIGN, SETTING, AND PARTICIPANTS: Retrospective study of patients 66 years and older diagnosed with cancer between 2004 and 2011, using population-based Surveillance, Epidemiology, and End Results (SEER)-Medicare data to assess physician-level variation in 5 nonrecommended services. Services included imaging for staging and surveillance in low-risk disease, intensity-modulated radiation therapy (IMRT) after breast-conserving surgery, and extended fractionation schemes for palliation of bone metastases. MAIN OUTCOME AND MEASURES: To assess variation in service use between physicians, we used a random effects model and a logistic regression model with a lag variable to assess whether a physician's use of a service for a prior patient predicts subsequent service use.
RESULTS: Cohorts ranged from 3464 to 89 006 patients. The total proportion of patients receiving each service varied from 14% for imaging in staging early breast cancer to 41% in early prostate cancer. From the random effects analysis, we found significant unexplained variation in service use between physicians (P < .001 for each service; ICC, 0.04-0.59). Controlling for case mix, whether a physician ordered a service for the prior patient was highly predictive of service use, with adjusted odds ratios (aORs) ranging from 1.12 (95% CI, 1.07-1.18) for surveillance imaging for patients with breast cancer (28% service use if prior patient had imaging vs 25% if not), to 24.91 (95% CI, 22.86-27.15) for IMRT for whole breast radiotherapy (69% vs 7%, respectively). CONCLUSIONS AND RELEVANCE: Physicians' utilization of nonrecommended services that tend to be overused exhibit patterns that suggest consistent behavior more than personalized patient care decisions. Reducing overuse may require understanding cognitive drivers of repetitive inappropriate decisions.

Entities:  

Mesh:

Year:  2016        PMID: 27533635      PMCID: PMC5363077          DOI: 10.1001/jamainternmed.2016.4426

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  34 in total

1.  Limits on Medicare's ability to control rising spending on cancer drugs.

Authors:  Peter B Bach
Journal:  N Engl J Med       Date:  2009-01-27       Impact factor: 91.245

2.  Provider Differences in Use of Implanted Ports in Older Adults With Cancer.

Authors:  Allison Lipitz-Snyderman; Elena B Elkin; Coral L Atoria; Camelia S Sima; Andrew S Epstein; Victoria Blinder; Kent A Sepkowitz; Peter B Bach
Journal:  Med Care       Date:  2015-07       Impact factor: 2.983

3.  A systemic approach to containing health care spending.

Authors:  Ezekiel Emanuel; Neera Tanden; Stuart Altman; Scott Armstrong; Donald Berwick; François de Brantes; Maura Calsyn; Michael Chernew; John Colmers; David Cutler; Tom Daschle; Paul Egerman; Bob Kocher; Arnold Milstein; Emily Oshima Lee; John D Podesta; Uwe Reinhardt; Meredith Rosenthal; Joshua Sharfstein; Stephen Shortell; Andrew Stern; Peter R Orszag; Topher Spiro
Journal:  N Engl J Med       Date:  2012-08-01       Impact factor: 91.245

4.  Bending the cost curve in cancer care.

Authors:  Thomas J Smith; Bruce E Hillner
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

Review 5.  Physician utilization. The state of research about physicians' practice patterns.

Authors:  J M Eisenberg
Journal:  Med Care       Date:  1985-05       Impact factor: 2.983

6.  Overuse of imaging for staging low risk prostate cancer.

Authors:  Wesley W Choi; Stephen B Williams; Xiangmei Gu; Stuart R Lipsitz; Paul L Nguyen; Jim C Hu
Journal:  J Urol       Date:  2011-03-17       Impact factor: 7.450

7.  The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population.

Authors:  Danil V Makarov; Rani A Desai; James B Yu; Richa Sharma; Nitya Abraham; Peter C Albertsen; David F Penson; Cary P Gross
Journal:  J Urol       Date:  2011-11-16       Impact factor: 7.450

8.  Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.

Authors:  Reshma Jagsi; Aaron D Falchook; Laura H Hendrix; Heather Curry; Ronald C Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-12-01       Impact factor: 7.038

9.  The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

10.  Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer.

Authors:  Justin E Bekelman; Andrew J Epstein; Ezekiel J Emanuel
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

View more
  25 in total

1.  Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.

Authors:  Aaron P Mitchell; Alan C Kinlaw; Sharon Peacock-Hinton; Stacie B Dusetzina; Hanna K Sanoff; Jennifer L Lund
Journal:  Oncologist       Date:  2019-10-14

Review 2.  Overuse of Health Care Services in the Management of Cancer: A Systematic Review.

Authors:  Shrujal S Baxi; Minal Kale; Salomeh Keyhani; Benjamin R Roman; Annie Yang; Antonio P Derosa; Deborah Korenstein
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

3.  Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference?

Authors:  Joan M Neuner; Ann B Nattinger; Tina Yen; Emily McGinley; Michael Nattinger; Liliana E Pezzin
Journal:  Breast Cancer Res Treat       Date:  2019-04-10       Impact factor: 4.872

Review 4.  Determinants of the overuse of imaging in low-risk prostate cancer: A systematic review.

Authors:  Allison H Oakes; Ritu Sharma; Madeline Jackson; Jodi B Segal
Journal:  Urol Oncol       Date:  2017-09-22       Impact factor: 3.498

5.  What drives variation in spending for breast cancer patients within geographic regions?

Authors:  Anna D Sinaiko; Alyna T Chien; Michael J Hassett; Pragya Kakani; Danielle Rodin; David J Meyers; Belen Fraile; Meredith B Rosenthal; Mary Beth Landrum
Journal:  Health Serv Res       Date:  2018-10-14       Impact factor: 3.402

6.  Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer.

Authors:  Penny Fang; Reshma Jagsi; Weiguo He; Xiudong Lei; Eric G Campbell; Sharon H Giordano; Grace L Smith
Journal:  J Clin Oncol       Date:  2019-05-29       Impact factor: 44.544

7.  Practice Patterns for Older Adult Patients With Advanced Cancer: Physician Office Versus Hospital Outpatient Setting.

Authors:  Allison Lipitz-Snyderman; Coral L Atoria; Stephen M Schleicher; Peter B Bach; Katherine S Panageas
Journal:  J Oncol Pract       Date:  2018-12-13       Impact factor: 3.840

8.  Low-Value Care and Excess Out-Of-Pocket Expenditure Among Older Adults with Incident Cancer - A Machine learning approach.

Authors:  Chibuzo Iloabuchi; Nilanjana Dwibedi; Traci LeMasters; Chan Shen; Amit Ladani; Usha Sambamoorthi
Journal:  J Cancer Policy       Date:  2021-10-29

9.  Clinician-Level Predictors for Ordering Low-Value Imaging.

Authors:  Arthur S Hong; Dennis Ross-Degnan; Fang Zhang; J Frank Wharam
Journal:  JAMA Intern Med       Date:  2017-11-01       Impact factor: 21.873

10.  Surgeons' Perceived Barriers to Palliative and End-of-Life Care: A Mixed Methods Study of a Surgical Society.

Authors:  Pasithorn A Suwanabol; Ari C Reichstein; Z Tuba Suzer-Gurtekin; Jane Forman; Maria J Silveira; Lona Mody; Arden M Morris
Journal:  J Palliat Med       Date:  2018-03-13       Impact factor: 2.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.